Editor Profile

Joel Yager, MD

Associate Editor

About the NEJM Journal Watch Psychiatry Board

Joel Yager, MD, is Professor, Department of Psychiatry, School of Medicine, University of Colorado. He also holds Emeritus Professor positions in the Department of Psychiatry at the University of New Mexico School of Medicine and in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA. Dr. Yager's clinical and research interests include eating disorders, psychiatric education, health services, and other aspects of general psychiatry. He has received the Goldberger Award in Clinical Nutrition from the American Medical Association, the Vestermark Award for Excellence in Psychiatric Education from the American Psychiatric Association and the NIMH, and the Distinguished Service Award from the Academy for Eating Disorders. Dr. Yager has been writing for NEJM Journal Watch Psychiatry since its inception in 1995.

Disclosures

Editorial boards

Bulletin of the Menninger Clinic; Eating Disorders Review (Editor-in-Chief Emeritus); International Journal of Eating Disorders; UpToDate; FOCUS: The Journal of Lifelong Learning in Psychiatry

Summaries by Joel Yager

  • July 21, 2016

    Identifying the Subtypes of Bipolar Depression

    1. Joel Yager, MD

    A sophisticated statistical analysis of depressive episodes in bipolar I and bipolar II patients reveals several possible subtypes distinguished by key clinical features.

  • July 21, 2016

    Quetiapine Monotherapy for Chronic Military PTSD?

    1. Joel Yager, MD

    Compared with placebo, quetiapine improved many mood and post-traumatic stress symptoms, but adverse effects led more quetiapine patients to drop out.

  • July 20, 2016

    A Novel ECT Strategy for Geriatric DepressionFree

    1. Joel Yager, MD

    Geriatric patients may benefit from unilateral, ultrabrief, pulsed electroconvulsive therapy plus venlafaxine, followed by a flexible ECT-medication strategy for relapse prevention or rescue.

  • July 11, 2016

    Binge-Eating Disorder: Treatments that Might Work

    1. Joel Yager, MD

    Benefits by the end of treatment are found for CBT, lisdexamfetamine, topiramate, and a group of antidepressants, but little is known about longer follow-ups.

  • June 22, 2016

    Add-On Antidepressants for Patients with SchizophreniaFree

    1. Joel Yager, MD

    High-quality evidence supports antidepressant–antipsychotic combinations, and perhaps particularly for patients with marked depressive or negative symptoms.

  • June 17, 2016

    Does Childhood Trauma Reduce Subsequent Response to Antidepressants?

    1. Joel Yager, MD

    In patients with major depression, childhood abuse histories were associated with lower responses to antidepressants, particularly sertraline.

Pages